Corteva Inc
Q3 2025 Earnings
Market Reaction
S&P 500 over the same 30 days: +0.89%.
Did CTVA Beat Earnings? Q3 2025 Results
Corteva turned in a notably strong third quarter, narrowing its seasonal loss far more than Wall Street had anticipated and raising its full-year outlook in the same breath. The agricultural sciences company posted a Q3 loss of $0.23 per share on an adjusted basis, beating the consensus estimate of $0.47 by 50.61%, while revenue of $2.62 billion topped expectations by 6.10% and grew 12.6% year over year. The primary engine behind the outperformance was a 33% surge in Seed segment sales to $917 million, fueled by a 27% volume increase tied to early safrinha corn deliveries in Brazil, acre recovery in Argentina, and stronger EMEA demand. Crop Protection contributed as well, with sales rising 4% to $1.70 billion on gains in new products, herbicides, and biologicals. Management lifted full-year 2025 guidance to net sales of $17.70 to $17.90 billion and operating EPS of $3.25 to $3.35, while also unveiling plans to separate into two independent public companies by the second half of 2026, a move that drew fresh institutional interest in the stock.
- 27% volume increase in Seed driven by early safrinha deliveries in Brazil and corn acre recovery in Argentina
- 5% Crop Protection volume increase driven by demand for new products, herbicides, and biologicals
- Productivity savings and cost deflation across both segments
- Increased out-licensing income and demand for top technology in Seed
- Price-for-value strategy execution in North America and EMEA
“We delivered a strong third quarter across the company, reinforcing our conviction that our two businesses will continue to thrive as independent public companies. In Crop Protection, demand for differentiated technology and productivity gains support margin expansion, while Seed continues to benefit from its strength in advanced genetics, growth in out-licensing and ongoing cost discipline.”
Corteva CEO, on the earnings call
Forward Guidance & Outlook
Corteva raised full-year 2025 guidance: net sales expected in the range of $17.7 billion to $17.9 billion (growth of ~5% at midpoint), Operating EBITDA of $3.8 billion to $3.9 billion (growth of 14% at midpoint), and Operating EPS of $3.25 to $3.35 per share (growth of 28% at midpoint). The company expects to repurchase approximately $1.0 billion of shares in 2025. For 2026, the preliminary Operating EBITDA view is $4.1 billion at midpoint, reflecting growth of ~6%. The global agriculture outlook is mixed with strong demand and production but pressured commodity prices and farmer margins. Global corn area increased in 2025, particularly in North America. The company expects no material net impact from ongoing tariff negotiations on full-year 2025 results given policies in place today. Corteva expects to record approximately $160 million to $175 million in net pre-tax restructuring charges during 2025 related to Crop Protection network optimization.
CTVA YoY Financials
CTVA Revenue by Segment
CTVA Revenue by Geography
Figures from SEC filings and company reports. Not investment advice.